Global Veterinary Genetic Engineering Vaccines Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Veterinary Genetic Engineering Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Genetic Engineering Vaccines.
The Veterinary Genetic Engineering Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Veterinary Genetic Engineering Vaccines market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Genetic Engineering Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Veterinary Genetic Engineering Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Veterinary Genetic Engineering Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The Veterinary Genetic Engineering Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Veterinary Genetic Engineering Vaccines market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Genetic Engineering Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
- Merck
- GSK
- Sanofi
- Zoties
- Elanco
- Boehringer Ingelheim
- Indian Immunologicals
- China Animal Husbandry Industry Co.,Ltd.
- Yebio Bioengineering Co., Ltd Of Qingdao
- Jinyu Bio-technology Co.,ltd.
- HVRI
- Ringpu Biology
- Kyoto Biken Laboratories
- FATRO
- Ceva Santй Animale
- Pulike Biological Engineering,Inc.
- Wuhan Hvsen Biotechnology CO.,LTD
- Jinhe Biotechnology Co., Ltd.
- Shanghai Shen Lian Biomedical Corporation
- Qingdao Vland Biotech INC.
- Genetic Recombinant Vaccine
- Recombinant Subunit Vaccines
- Genetic Vaccine
- Poultry
- Livestock
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Southeast Asia
- Latin America
- Mexico
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Veterinary Genetic Engineering Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Veterinary Genetic Engineering Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 VETERINARY GENETIC ENGINEERING VACCINES MARKET OVERVIEW
1.1 Product Overview and Scope of Veterinary Genetic Engineering Vaccines
1.2 Veterinary Genetic Engineering Vaccines Segment by Type
1.2.1 Global Veterinary Genetic Engineering Vaccines Market Value Comparison by Type (2023-2029)
1.2.2 Genetic Recombinant Vaccine
1.2.3 Recombinant Subunit Vaccines
1.2.4 Genetic Vaccine
1.3 Veterinary Genetic Engineering Vaccines Segment by Application
1.3.1 Global Veterinary Genetic Engineering Vaccines Market Value by Application: (2023-2029)
1.3.2 Poultry
1.3.3 Livestock
1.3.4 Other
1.4 Global Veterinary Genetic Engineering Vaccines Market Size Estimates and Forecasts
1.4.1 Global Veterinary Genetic Engineering Vaccines Revenue 2018-2029
1.4.2 Global Veterinary Genetic Engineering Vaccines Sales 2018-2029
1.4.3 Global Veterinary Genetic Engineering Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 VETERINARY GENETIC ENGINEERING VACCINES MARKET COMPETITION BY MANUFACTURERS
2.1 Global Veterinary Genetic Engineering Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Veterinary Genetic Engineering Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global Veterinary Genetic Engineering Vaccines Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Veterinary Genetic Engineering Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Genetic Engineering Vaccines, Product Type & Application
2.7 Veterinary Genetic Engineering Vaccines Market Competitive Situation and Trends
2.7.1 Veterinary Genetic Engineering Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Veterinary Genetic Engineering Vaccines Players Market Share by Revenue
2.7.3 Global Veterinary Genetic Engineering Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 VETERINARY GENETIC ENGINEERING VACCINES RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Veterinary Genetic Engineering Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Veterinary Genetic Engineering Vaccines Global Veterinary Genetic Engineering Vaccines Sales by Region: 2018-2029
3.2.1 Global Veterinary Genetic Engineering Vaccines Sales by Region: 2018-2023
3.2.2 Global Veterinary Genetic Engineering Vaccines Sales by Region: 2024-2029
3.3 Global Veterinary Genetic Engineering Vaccines Global Veterinary Genetic Engineering Vaccines Revenue by Region: 2018-2029
3.3.1 Global Veterinary Genetic Engineering Vaccines Revenue by Region: 2018-2023
3.3.2 Global Veterinary Genetic Engineering Vaccines Revenue by Region: 2024-2029
3.4 North America Veterinary Genetic Engineering Vaccines Market Facts & Figures by Country
3.4.1 North America Veterinary Genetic Engineering Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Veterinary Genetic Engineering Vaccines Sales by Country (2018-2029)
3.4.3 North America Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary Genetic Engineering Vaccines Market Facts & Figures by Country
3.5.1 Europe Veterinary Genetic Engineering Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Veterinary Genetic Engineering Vaccines Sales by Country (2018-2029)
3.5.3 Europe Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Genetic Engineering Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Veterinary Genetic Engineering Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Veterinary Genetic Engineering Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Veterinary Genetic Engineering Vaccines Market Facts & Figures by Country
3.7.1 Latin America Veterinary Genetic Engineering Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Veterinary Genetic Engineering Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Veterinary Genetic Engineering Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Genetic Engineering Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Veterinary Genetic Engineering Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Veterinary Genetic Engineering Vaccines Sales by Type (2018-2029)
4.1.1 Global Veterinary Genetic Engineering Vaccines Sales by Type (2018-2023)
4.1.2 Global Veterinary Genetic Engineering Vaccines Sales by Type (2024-2029)
4.1.3 Global Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Veterinary Genetic Engineering Vaccines Revenue by Type (2018-2029)
4.2.1 Global Veterinary Genetic Engineering Vaccines Revenue by Type (2018-2023)
4.2.2 Global Veterinary Genetic Engineering Vaccines Revenue by Type (2024-2029)
4.2.3 Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Veterinary Genetic Engineering Vaccines Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Veterinary Genetic Engineering Vaccines Sales by Application (2018-2029)
5.1.1 Global Veterinary Genetic Engineering Vaccines Sales by Application (2018-2023)
5.1.2 Global Veterinary Genetic Engineering Vaccines Sales by Application (2024-2029)
5.1.3 Global Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Veterinary Genetic Engineering Vaccines Revenue by Application (2018-2029)
5.2.1 Global Veterinary Genetic Engineering Vaccines Revenue by Application (2018-2023)
5.2.2 Global Veterinary Genetic Engineering Vaccines Revenue by Application (2024-2029)
5.2.3 Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Veterinary Genetic Engineering Vaccines Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Veterinary Genetic Engineering Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GSK Veterinary Genetic Engineering Vaccines Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi Veterinary Genetic Engineering Vaccines Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Zoties
6.4.1 Zoties Corporation Information
6.4.2 Zoties Description and Business Overview
6.4.3 Zoties Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zoties Veterinary Genetic Engineering Vaccines Product Portfolio
6.4.5 Zoties Recent Developments/Updates
6.5 Elanco
6.5.1 Elanco Corporation Information
6.5.2 Elanco Description and Business Overview
6.5.3 Elanco Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Elanco Veterinary Genetic Engineering Vaccines Product Portfolio
6.5.5 Elanco Recent Developments/Updates
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments/Updates
6.7 Indian Immunologicals
6.6.1 Indian Immunologicals Corporation Information
6.6.2 Indian Immunologicals Description and Business Overview
6.6.3 Indian Immunologicals Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Indian Immunologicals Veterinary Genetic Engineering Vaccines Product Portfolio
6.7.5 Indian Immunologicals Recent Developments/Updates
6.8 China Animal Husbandry Industry Co.,Ltd.
6.8.1 China Animal Husbandry Industry Co.,Ltd. Corporation Information
6.8.2 China Animal Husbandry Industry Co.,Ltd. Description and Business Overview
6.8.3 China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.8.4 China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Product Portfolio
6.8.5 China Animal Husbandry Industry Co.,Ltd. Recent Developments/Updates
6.9 Yebio Bioengineering Co., Ltd Of Qingdao
6.9.1 Yebio Bioengineering Co., Ltd Of Qingdao Corporation Information
6.9.2 Yebio Bioengineering Co., Ltd Of Qingdao Description and Business Overview
6.9.3 Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Product Portfolio
6.9.5 Yebio Bioengineering Co., Ltd Of Qingdao Recent Developments/Updates
6.10 Jinyu Bio-technology Co.,ltd.
6.10.1 Jinyu Bio-technology Co.,ltd. Corporation Information
6.10.2 Jinyu Bio-technology Co.,ltd. Description and Business Overview
6.10.3 Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Product Portfolio
6.10.5 Jinyu Bio-technology Co.,ltd. Recent Developments/Updates
6.11 HVRI
6.11.1 HVRI Corporation Information
6.11.2 HVRI Veterinary Genetic Engineering Vaccines Description and Business Overview
6.11.3 HVRI Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.11.4 HVRI Veterinary Genetic Engineering Vaccines Product Portfolio
6.11.5 HVRI Recent Developments/Updates
6.12 Ringpu Biology
6.12.1 Ringpu Biology Corporation Information
6.12.2 Ringpu Biology Veterinary Genetic Engineering Vaccines Description and Business Overview
6.12.3 Ringpu Biology Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Ringpu Biology Veterinary Genetic Engineering Vaccines Product Portfolio
6.12.5 Ringpu Biology Recent Developments/Updates
6.13 Kyoto Biken Laboratories
6.13.1 Kyoto Biken Laboratories Corporation Information
6.13.2 Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Description and Business Overview
6.13.3 Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Product Portfolio
6.13.5 Kyoto Biken Laboratories Recent Developments/Updates
6.14 FATRO
6.14.1 FATRO Corporation Information
6.14.2 FATRO Veterinary Genetic Engineering Vaccines Description and Business Overview
6.14.3 FATRO Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.14.4 FATRO Veterinary Genetic Engineering Vaccines Product Portfolio
6.14.5 FATRO Recent Developments/Updates
6.15 Ceva Santй Animale
6.15.1 Ceva Santй Animale Corporation Information
6.15.2 Ceva Santй Animale Veterinary Genetic Engineering Vaccines Description and Business Overview
6.15.3 Ceva Santй Animale Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Ceva Santй Animale Veterinary Genetic Engineering Vaccines Product Portfolio
6.15.5 Ceva Santй Animale Recent Developments/Updates
6.16 Pulike Biological Engineering,Inc.
6.16.1 Pulike Biological Engineering,Inc. Corporation Information
6.16.2 Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Description and Business Overview
6.16.3 Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Product Portfolio
6.16.5 Pulike Biological Engineering,Inc. Recent Developments/Updates
6.17 Wuhan Hvsen Biotechnology CO.,LTD
6.17.1 Wuhan Hvsen Biotechnology CO.,LTD Corporation Information
6.17.2 Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Description and Business Overview
6.17.3 Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Product Portfolio
6.17.5 Wuhan Hvsen Biotechnology CO.,LTD Recent Developments/Updates
6.18 Jinhe Biotechnology Co., Ltd.
6.18.1 Jinhe Biotechnology Co., Ltd. Corporation Information
6.18.2 Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Description and Business Overview
6.18.3 Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Product Portfolio
6.18.5 Jinhe Biotechnology Co., Ltd. Recent Developments/Updates
6.19 Shanghai Shen Lian Biomedical Corporation
6.19.1 Shanghai Shen Lian Biomedical Corporation Corporation Information
6.19.2 Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Description and Business Overview
6.19.3 Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Product Portfolio
6.19.5 Shanghai Shen Lian Biomedical Corporation Recent Developments/Updates
6.20 Qingdao Vland Biotech INC.
6.20.1 Qingdao Vland Biotech INC. Corporation Information
6.20.2 Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Description and Business Overview
6.20.3 Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Product Portfolio
6.20.5 Qingdao Vland Biotech INC. Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Veterinary Genetic Engineering Vaccines Industry Chain Analysis
7.2 Veterinary Genetic Engineering Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Genetic Engineering Vaccines Production Mode & Process
7.4 Veterinary Genetic Engineering Vaccines Sales and Marketing
7.4.1 Veterinary Genetic Engineering Vaccines Sales Channels
7.4.2 Veterinary Genetic Engineering Vaccines Distributors
7.5 Veterinary Genetic Engineering Vaccines Customers
8 VETERINARY GENETIC ENGINEERING VACCINES MARKET DYNAMICS
8.1 Veterinary Genetic Engineering Vaccines Industry Trends
8.2 Veterinary Genetic Engineering Vaccines Market Drivers
8.3 Veterinary Genetic Engineering Vaccines Market Challenges
8.4 Veterinary Genetic Engineering Vaccines Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Veterinary Genetic Engineering Vaccines
1.2 Veterinary Genetic Engineering Vaccines Segment by Type
1.2.1 Global Veterinary Genetic Engineering Vaccines Market Value Comparison by Type (2023-2029)
1.2.2 Genetic Recombinant Vaccine
1.2.3 Recombinant Subunit Vaccines
1.2.4 Genetic Vaccine
1.3 Veterinary Genetic Engineering Vaccines Segment by Application
1.3.1 Global Veterinary Genetic Engineering Vaccines Market Value by Application: (2023-2029)
1.3.2 Poultry
1.3.3 Livestock
1.3.4 Other
1.4 Global Veterinary Genetic Engineering Vaccines Market Size Estimates and Forecasts
1.4.1 Global Veterinary Genetic Engineering Vaccines Revenue 2018-2029
1.4.2 Global Veterinary Genetic Engineering Vaccines Sales 2018-2029
1.4.3 Global Veterinary Genetic Engineering Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 VETERINARY GENETIC ENGINEERING VACCINES MARKET COMPETITION BY MANUFACTURERS
2.1 Global Veterinary Genetic Engineering Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Veterinary Genetic Engineering Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global Veterinary Genetic Engineering Vaccines Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Veterinary Genetic Engineering Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Genetic Engineering Vaccines, Product Type & Application
2.7 Veterinary Genetic Engineering Vaccines Market Competitive Situation and Trends
2.7.1 Veterinary Genetic Engineering Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Veterinary Genetic Engineering Vaccines Players Market Share by Revenue
2.7.3 Global Veterinary Genetic Engineering Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 VETERINARY GENETIC ENGINEERING VACCINES RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Veterinary Genetic Engineering Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Veterinary Genetic Engineering Vaccines Global Veterinary Genetic Engineering Vaccines Sales by Region: 2018-2029
3.2.1 Global Veterinary Genetic Engineering Vaccines Sales by Region: 2018-2023
3.2.2 Global Veterinary Genetic Engineering Vaccines Sales by Region: 2024-2029
3.3 Global Veterinary Genetic Engineering Vaccines Global Veterinary Genetic Engineering Vaccines Revenue by Region: 2018-2029
3.3.1 Global Veterinary Genetic Engineering Vaccines Revenue by Region: 2018-2023
3.3.2 Global Veterinary Genetic Engineering Vaccines Revenue by Region: 2024-2029
3.4 North America Veterinary Genetic Engineering Vaccines Market Facts & Figures by Country
3.4.1 North America Veterinary Genetic Engineering Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Veterinary Genetic Engineering Vaccines Sales by Country (2018-2029)
3.4.3 North America Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary Genetic Engineering Vaccines Market Facts & Figures by Country
3.5.1 Europe Veterinary Genetic Engineering Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Veterinary Genetic Engineering Vaccines Sales by Country (2018-2029)
3.5.3 Europe Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Genetic Engineering Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Veterinary Genetic Engineering Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Veterinary Genetic Engineering Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Veterinary Genetic Engineering Vaccines Market Facts & Figures by Country
3.7.1 Latin America Veterinary Genetic Engineering Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Veterinary Genetic Engineering Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Veterinary Genetic Engineering Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Genetic Engineering Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Veterinary Genetic Engineering Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Veterinary Genetic Engineering Vaccines Sales by Type (2018-2029)
4.1.1 Global Veterinary Genetic Engineering Vaccines Sales by Type (2018-2023)
4.1.2 Global Veterinary Genetic Engineering Vaccines Sales by Type (2024-2029)
4.1.3 Global Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Veterinary Genetic Engineering Vaccines Revenue by Type (2018-2029)
4.2.1 Global Veterinary Genetic Engineering Vaccines Revenue by Type (2018-2023)
4.2.2 Global Veterinary Genetic Engineering Vaccines Revenue by Type (2024-2029)
4.2.3 Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Veterinary Genetic Engineering Vaccines Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Veterinary Genetic Engineering Vaccines Sales by Application (2018-2029)
5.1.1 Global Veterinary Genetic Engineering Vaccines Sales by Application (2018-2023)
5.1.2 Global Veterinary Genetic Engineering Vaccines Sales by Application (2024-2029)
5.1.3 Global Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Veterinary Genetic Engineering Vaccines Revenue by Application (2018-2029)
5.2.1 Global Veterinary Genetic Engineering Vaccines Revenue by Application (2018-2023)
5.2.2 Global Veterinary Genetic Engineering Vaccines Revenue by Application (2024-2029)
5.2.3 Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Veterinary Genetic Engineering Vaccines Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Veterinary Genetic Engineering Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GSK Veterinary Genetic Engineering Vaccines Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi Veterinary Genetic Engineering Vaccines Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Zoties
6.4.1 Zoties Corporation Information
6.4.2 Zoties Description and Business Overview
6.4.3 Zoties Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zoties Veterinary Genetic Engineering Vaccines Product Portfolio
6.4.5 Zoties Recent Developments/Updates
6.5 Elanco
6.5.1 Elanco Corporation Information
6.5.2 Elanco Description and Business Overview
6.5.3 Elanco Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Elanco Veterinary Genetic Engineering Vaccines Product Portfolio
6.5.5 Elanco Recent Developments/Updates
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments/Updates
6.7 Indian Immunologicals
6.6.1 Indian Immunologicals Corporation Information
6.6.2 Indian Immunologicals Description and Business Overview
6.6.3 Indian Immunologicals Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Indian Immunologicals Veterinary Genetic Engineering Vaccines Product Portfolio
6.7.5 Indian Immunologicals Recent Developments/Updates
6.8 China Animal Husbandry Industry Co.,Ltd.
6.8.1 China Animal Husbandry Industry Co.,Ltd. Corporation Information
6.8.2 China Animal Husbandry Industry Co.,Ltd. Description and Business Overview
6.8.3 China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.8.4 China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Product Portfolio
6.8.5 China Animal Husbandry Industry Co.,Ltd. Recent Developments/Updates
6.9 Yebio Bioengineering Co., Ltd Of Qingdao
6.9.1 Yebio Bioengineering Co., Ltd Of Qingdao Corporation Information
6.9.2 Yebio Bioengineering Co., Ltd Of Qingdao Description and Business Overview
6.9.3 Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Product Portfolio
6.9.5 Yebio Bioengineering Co., Ltd Of Qingdao Recent Developments/Updates
6.10 Jinyu Bio-technology Co.,ltd.
6.10.1 Jinyu Bio-technology Co.,ltd. Corporation Information
6.10.2 Jinyu Bio-technology Co.,ltd. Description and Business Overview
6.10.3 Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Product Portfolio
6.10.5 Jinyu Bio-technology Co.,ltd. Recent Developments/Updates
6.11 HVRI
6.11.1 HVRI Corporation Information
6.11.2 HVRI Veterinary Genetic Engineering Vaccines Description and Business Overview
6.11.3 HVRI Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.11.4 HVRI Veterinary Genetic Engineering Vaccines Product Portfolio
6.11.5 HVRI Recent Developments/Updates
6.12 Ringpu Biology
6.12.1 Ringpu Biology Corporation Information
6.12.2 Ringpu Biology Veterinary Genetic Engineering Vaccines Description and Business Overview
6.12.3 Ringpu Biology Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Ringpu Biology Veterinary Genetic Engineering Vaccines Product Portfolio
6.12.5 Ringpu Biology Recent Developments/Updates
6.13 Kyoto Biken Laboratories
6.13.1 Kyoto Biken Laboratories Corporation Information
6.13.2 Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Description and Business Overview
6.13.3 Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Product Portfolio
6.13.5 Kyoto Biken Laboratories Recent Developments/Updates
6.14 FATRO
6.14.1 FATRO Corporation Information
6.14.2 FATRO Veterinary Genetic Engineering Vaccines Description and Business Overview
6.14.3 FATRO Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.14.4 FATRO Veterinary Genetic Engineering Vaccines Product Portfolio
6.14.5 FATRO Recent Developments/Updates
6.15 Ceva Santй Animale
6.15.1 Ceva Santй Animale Corporation Information
6.15.2 Ceva Santй Animale Veterinary Genetic Engineering Vaccines Description and Business Overview
6.15.3 Ceva Santй Animale Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Ceva Santй Animale Veterinary Genetic Engineering Vaccines Product Portfolio
6.15.5 Ceva Santй Animale Recent Developments/Updates
6.16 Pulike Biological Engineering,Inc.
6.16.1 Pulike Biological Engineering,Inc. Corporation Information
6.16.2 Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Description and Business Overview
6.16.3 Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Product Portfolio
6.16.5 Pulike Biological Engineering,Inc. Recent Developments/Updates
6.17 Wuhan Hvsen Biotechnology CO.,LTD
6.17.1 Wuhan Hvsen Biotechnology CO.,LTD Corporation Information
6.17.2 Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Description and Business Overview
6.17.3 Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Product Portfolio
6.17.5 Wuhan Hvsen Biotechnology CO.,LTD Recent Developments/Updates
6.18 Jinhe Biotechnology Co., Ltd.
6.18.1 Jinhe Biotechnology Co., Ltd. Corporation Information
6.18.2 Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Description and Business Overview
6.18.3 Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Product Portfolio
6.18.5 Jinhe Biotechnology Co., Ltd. Recent Developments/Updates
6.19 Shanghai Shen Lian Biomedical Corporation
6.19.1 Shanghai Shen Lian Biomedical Corporation Corporation Information
6.19.2 Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Description and Business Overview
6.19.3 Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Product Portfolio
6.19.5 Shanghai Shen Lian Biomedical Corporation Recent Developments/Updates
6.20 Qingdao Vland Biotech INC.
6.20.1 Qingdao Vland Biotech INC. Corporation Information
6.20.2 Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Description and Business Overview
6.20.3 Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Product Portfolio
6.20.5 Qingdao Vland Biotech INC. Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Veterinary Genetic Engineering Vaccines Industry Chain Analysis
7.2 Veterinary Genetic Engineering Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Genetic Engineering Vaccines Production Mode & Process
7.4 Veterinary Genetic Engineering Vaccines Sales and Marketing
7.4.1 Veterinary Genetic Engineering Vaccines Sales Channels
7.4.2 Veterinary Genetic Engineering Vaccines Distributors
7.5 Veterinary Genetic Engineering Vaccines Customers
8 VETERINARY GENETIC ENGINEERING VACCINES MARKET DYNAMICS
8.1 Veterinary Genetic Engineering Vaccines Industry Trends
8.2 Veterinary Genetic Engineering Vaccines Market Drivers
8.3 Veterinary Genetic Engineering Vaccines Market Challenges
8.4 Veterinary Genetic Engineering Vaccines Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Veterinary Genetic Engineering Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Veterinary Genetic Engineering Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Veterinary Genetic Engineering Vaccines Market Competitive Situation by Manufacturers in 2022
Table 4. Global Veterinary Genetic Engineering Vaccines Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Veterinary Genetic Engineering Vaccines Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Veterinary Genetic Engineering Vaccines Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Veterinary Genetic Engineering Vaccines Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Veterinary Genetic Engineering Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Veterinary Genetic Engineering Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Veterinary Genetic Engineering Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Veterinary Genetic Engineering Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Veterinary Genetic Engineering Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Genetic Engineering Vaccines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Veterinary Genetic Engineering Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Veterinary Genetic Engineering Vaccines Sales by Region (2018-2023) & (K Units)
Table 18. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Region (2018-2023)
Table 19. Global Veterinary Genetic Engineering Vaccines Sales by Region (2024-2029) & (K Units)
Table 20. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Region (2024-2029)
Table 21. Global Veterinary Genetic Engineering Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Region (2018-2023)
Table 23. Global Veterinary Genetic Engineering Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Region (2024-2029)
Table 25. North America Veterinary Genetic Engineering Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Veterinary Genetic Engineering Vaccines Sales by Country (2018-2023) & (K Units)
Table 27. North America Veterinary Genetic Engineering Vaccines Sales by Country (2024-2029) & (K Units)
Table 28. North America Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Veterinary Genetic Engineering Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Veterinary Genetic Engineering Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Veterinary Genetic Engineering Vaccines Sales by Country (2018-2023) & (K Units)
Table 32. Europe Veterinary Genetic Engineering Vaccines Sales by Country (2024-2029) & (K Units)
Table 33. Europe Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Veterinary Genetic Engineering Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Veterinary Genetic Engineering Vaccines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Veterinary Genetic Engineering Vaccines Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Veterinary Genetic Engineering Vaccines Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Veterinary Genetic Engineering Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Veterinary Genetic Engineering Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Veterinary Genetic Engineering Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Veterinary Genetic Engineering Vaccines Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Veterinary Genetic Engineering Vaccines Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Veterinary Genetic Engineering Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Veterinary Genetic Engineering Vaccines Sales (K Units) by Type (2018-2023)
Table 51. Global Veterinary Genetic Engineering Vaccines Sales (K Units) by Type (2024-2029)
Table 52. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2018-2023)
Table 53. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2024-2029)
Table 54. Global Veterinary Genetic Engineering Vaccines Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Veterinary Genetic Engineering Vaccines Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Type (2018-2023)
Table 57. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Type (2024-2029)
Table 58. Global Veterinary Genetic Engineering Vaccines Price (US$/Unit) by Type (2018-2023)
Table 59. Global Veterinary Genetic Engineering Vaccines Price (US$/Unit) by Type (2024-2029)
Table 60. Global Veterinary Genetic Engineering Vaccines Sales (K Units) by Application (2018-2023)
Table 61. Global Veterinary Genetic Engineering Vaccines Sales (K Units) by Application (2024-2029)
Table 62. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2018-2023)
Table 63. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2024-2029)
Table 64. Global Veterinary Genetic Engineering Vaccines Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Veterinary Genetic Engineering Vaccines Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Application (2018-2023)
Table 67. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Application (2024-2029)
Table 68. Global Veterinary Genetic Engineering Vaccines Price (US$/Unit) by Application (2018-2023)
Table 69. Global Veterinary Genetic Engineering Vaccines Price (US$/Unit) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Merck Veterinary Genetic Engineering Vaccines Product
Table 74. Merck Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. GSK Veterinary Genetic Engineering Vaccines Product
Table 79. GSK Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Sanofi Veterinary Genetic Engineering Vaccines Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Zoties Corporation Information
Table 86. Zoties Description and Business Overview
Table 87. Zoties Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Zoties Veterinary Genetic Engineering Vaccines Product
Table 89. Zoties Recent Developments/Updates
Table 90. Elanco Corporation Information
Table 91. Elanco Description and Business Overview
Table 92. Elanco Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Elanco Veterinary Genetic Engineering Vaccines Product
Table 94. Elanco Recent Developments/Updates
Table 95. Boehringer Ingelheim Corporation Information
Table 96. Boehringer Ingelheim Description and Business Overview
Table 97. Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Product
Table 99. Boehringer Ingelheim Recent Developments/Updates
Table 100. Indian Immunologicals Corporation Information
Table 101. Indian Immunologicals Description and Business Overview
Table 102. Indian Immunologicals Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Indian Immunologicals Veterinary Genetic Engineering Vaccines Product
Table 104. Indian Immunologicals Recent Developments/Updates
Table 105. China Animal Husbandry Industry Co.,Ltd. Corporation Information
Table 106. China Animal Husbandry Industry Co.,Ltd. Description and Business Overview
Table 107. China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Product
Table 109. China Animal Husbandry Industry Co.,Ltd. Recent Developments/Updates
Table 110. Yebio Bioengineering Co., Ltd Of Qingdao Corporation Information
Table 111. Yebio Bioengineering Co., Ltd Of Qingdao Description and Business Overview
Table 112. Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Product
Table 114. Yebio Bioengineering Co., Ltd Of Qingdao Recent Developments/Updates
Table 115. Jinyu Bio-technology Co.,ltd. Corporation Information
Table 116. Jinyu Bio-technology Co.,ltd. Description and Business Overview
Table 117. Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Product
Table 119. Jinyu Bio-technology Co.,ltd. Recent Developments/Updates
Table 120. HVRI Corporation Information
Table 121. HVRI Description and Business Overview
Table 122. HVRI Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. HVRI Veterinary Genetic Engineering Vaccines Product
Table 124. HVRI Recent Developments/Updates
Table 125. Ringpu Biology Corporation Information
Table 126. Ringpu Biology Description and Business Overview
Table 127. Ringpu Biology Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Ringpu Biology Veterinary Genetic Engineering Vaccines Product
Table 129. Ringpu Biology Recent Developments/Updates
Table 130. Kyoto Biken Laboratories Corporation Information
Table 131. Kyoto Biken Laboratories Description and Business Overview
Table 132. Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Product
Table 134. Kyoto Biken Laboratories Recent Developments/Updates
Table 135. FATRO Corporation Information
Table 136. FATRO Description and Business Overview
Table 137. FATRO Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. FATRO Veterinary Genetic Engineering Vaccines Product
Table 139. FATRO Recent Developments/Updates
Table 140. Ceva Santй Animale Corporation Information
Table 141. Ceva Santй Animale Description and Business Overview
Table 142. Ceva Santй Animale Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Ceva Santй Animale Veterinary Genetic Engineering Vaccines Product
Table 144. Ceva Santй Animale Recent Developments/Updates
Table 145. Pulike Biological Engineering,Inc. Corporation Information
Table 146. Pulike Biological Engineering,Inc. Description and Business Overview
Table 147. Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Product
Table 149. Pulike Biological Engineering,Inc. Recent Developments/Updates
Table 150. Wuhan Hvsen Biotechnology CO.,LTD Corporation Information
Table 151. Wuhan Hvsen Biotechnology CO.,LTD Description and Business Overview
Table 152. Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Product
Table 154. Wuhan Hvsen Biotechnology CO.,LTD Recent Developments/Updates
Table 155. Jinhe Biotechnology Co., Ltd. Corporation Information
Table 156. Jinhe Biotechnology Co., Ltd. Description and Business Overview
Table 157. Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Product
Table 159. Jinhe Biotechnology Co., Ltd. Recent Developments/Updates
Table 160. Shanghai Shen Lian Biomedical Corporation Corporation Information
Table 161. Shanghai Shen Lian Biomedical Corporation Description and Business Overview
Table 162. Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Product
Table 164. Shanghai Shen Lian Biomedical Corporation Recent Developments/Updates
Table 165. Qingdao Vland Biotech INC. Corporation Information
Table 166. Qingdao Vland Biotech INC. Description and Business Overview
Table 167. Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 168. Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Product
Table 169. Qingdao Vland Biotech INC. Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Veterinary Genetic Engineering Vaccines Distributors List
Table 173. Veterinary Genetic Engineering Vaccines Customers List
Table 174. Veterinary Genetic Engineering Vaccines Market Trends
Table 175. Veterinary Genetic Engineering Vaccines Market Drivers
Table 176. Veterinary Genetic Engineering Vaccines Market Challenges
Table 177. Veterinary Genetic Engineering Vaccines Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 1. Global Veterinary Genetic Engineering Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Veterinary Genetic Engineering Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Veterinary Genetic Engineering Vaccines Market Competitive Situation by Manufacturers in 2022
Table 4. Global Veterinary Genetic Engineering Vaccines Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Veterinary Genetic Engineering Vaccines Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Veterinary Genetic Engineering Vaccines Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Veterinary Genetic Engineering Vaccines Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Veterinary Genetic Engineering Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Veterinary Genetic Engineering Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Veterinary Genetic Engineering Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Veterinary Genetic Engineering Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Veterinary Genetic Engineering Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Genetic Engineering Vaccines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Veterinary Genetic Engineering Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Veterinary Genetic Engineering Vaccines Sales by Region (2018-2023) & (K Units)
Table 18. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Region (2018-2023)
Table 19. Global Veterinary Genetic Engineering Vaccines Sales by Region (2024-2029) & (K Units)
Table 20. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Region (2024-2029)
Table 21. Global Veterinary Genetic Engineering Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Region (2018-2023)
Table 23. Global Veterinary Genetic Engineering Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Region (2024-2029)
Table 25. North America Veterinary Genetic Engineering Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Veterinary Genetic Engineering Vaccines Sales by Country (2018-2023) & (K Units)
Table 27. North America Veterinary Genetic Engineering Vaccines Sales by Country (2024-2029) & (K Units)
Table 28. North America Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Veterinary Genetic Engineering Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Veterinary Genetic Engineering Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Veterinary Genetic Engineering Vaccines Sales by Country (2018-2023) & (K Units)
Table 32. Europe Veterinary Genetic Engineering Vaccines Sales by Country (2024-2029) & (K Units)
Table 33. Europe Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Veterinary Genetic Engineering Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Veterinary Genetic Engineering Vaccines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Veterinary Genetic Engineering Vaccines Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Veterinary Genetic Engineering Vaccines Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Veterinary Genetic Engineering Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Veterinary Genetic Engineering Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Veterinary Genetic Engineering Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Veterinary Genetic Engineering Vaccines Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Veterinary Genetic Engineering Vaccines Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Veterinary Genetic Engineering Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Veterinary Genetic Engineering Vaccines Sales (K Units) by Type (2018-2023)
Table 51. Global Veterinary Genetic Engineering Vaccines Sales (K Units) by Type (2024-2029)
Table 52. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2018-2023)
Table 53. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Type (2024-2029)
Table 54. Global Veterinary Genetic Engineering Vaccines Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Veterinary Genetic Engineering Vaccines Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Type (2018-2023)
Table 57. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Type (2024-2029)
Table 58. Global Veterinary Genetic Engineering Vaccines Price (US$/Unit) by Type (2018-2023)
Table 59. Global Veterinary Genetic Engineering Vaccines Price (US$/Unit) by Type (2024-2029)
Table 60. Global Veterinary Genetic Engineering Vaccines Sales (K Units) by Application (2018-2023)
Table 61. Global Veterinary Genetic Engineering Vaccines Sales (K Units) by Application (2024-2029)
Table 62. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2018-2023)
Table 63. Global Veterinary Genetic Engineering Vaccines Sales Market Share by Application (2024-2029)
Table 64. Global Veterinary Genetic Engineering Vaccines Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Veterinary Genetic Engineering Vaccines Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Application (2018-2023)
Table 67. Global Veterinary Genetic Engineering Vaccines Revenue Market Share by Application (2024-2029)
Table 68. Global Veterinary Genetic Engineering Vaccines Price (US$/Unit) by Application (2018-2023)
Table 69. Global Veterinary Genetic Engineering Vaccines Price (US$/Unit) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Merck Veterinary Genetic Engineering Vaccines Product
Table 74. Merck Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. GSK Veterinary Genetic Engineering Vaccines Product
Table 79. GSK Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Sanofi Veterinary Genetic Engineering Vaccines Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Zoties Corporation Information
Table 86. Zoties Description and Business Overview
Table 87. Zoties Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Zoties Veterinary Genetic Engineering Vaccines Product
Table 89. Zoties Recent Developments/Updates
Table 90. Elanco Corporation Information
Table 91. Elanco Description and Business Overview
Table 92. Elanco Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Elanco Veterinary Genetic Engineering Vaccines Product
Table 94. Elanco Recent Developments/Updates
Table 95. Boehringer Ingelheim Corporation Information
Table 96. Boehringer Ingelheim Description and Business Overview
Table 97. Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Boehringer Ingelheim Veterinary Genetic Engineering Vaccines Product
Table 99. Boehringer Ingelheim Recent Developments/Updates
Table 100. Indian Immunologicals Corporation Information
Table 101. Indian Immunologicals Description and Business Overview
Table 102. Indian Immunologicals Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Indian Immunologicals Veterinary Genetic Engineering Vaccines Product
Table 104. Indian Immunologicals Recent Developments/Updates
Table 105. China Animal Husbandry Industry Co.,Ltd. Corporation Information
Table 106. China Animal Husbandry Industry Co.,Ltd. Description and Business Overview
Table 107. China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. China Animal Husbandry Industry Co.,Ltd. Veterinary Genetic Engineering Vaccines Product
Table 109. China Animal Husbandry Industry Co.,Ltd. Recent Developments/Updates
Table 110. Yebio Bioengineering Co., Ltd Of Qingdao Corporation Information
Table 111. Yebio Bioengineering Co., Ltd Of Qingdao Description and Business Overview
Table 112. Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Yebio Bioengineering Co., Ltd Of Qingdao Veterinary Genetic Engineering Vaccines Product
Table 114. Yebio Bioengineering Co., Ltd Of Qingdao Recent Developments/Updates
Table 115. Jinyu Bio-technology Co.,ltd. Corporation Information
Table 116. Jinyu Bio-technology Co.,ltd. Description and Business Overview
Table 117. Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Jinyu Bio-technology Co.,ltd. Veterinary Genetic Engineering Vaccines Product
Table 119. Jinyu Bio-technology Co.,ltd. Recent Developments/Updates
Table 120. HVRI Corporation Information
Table 121. HVRI Description and Business Overview
Table 122. HVRI Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. HVRI Veterinary Genetic Engineering Vaccines Product
Table 124. HVRI Recent Developments/Updates
Table 125. Ringpu Biology Corporation Information
Table 126. Ringpu Biology Description and Business Overview
Table 127. Ringpu Biology Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Ringpu Biology Veterinary Genetic Engineering Vaccines Product
Table 129. Ringpu Biology Recent Developments/Updates
Table 130. Kyoto Biken Laboratories Corporation Information
Table 131. Kyoto Biken Laboratories Description and Business Overview
Table 132. Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Kyoto Biken Laboratories Veterinary Genetic Engineering Vaccines Product
Table 134. Kyoto Biken Laboratories Recent Developments/Updates
Table 135. FATRO Corporation Information
Table 136. FATRO Description and Business Overview
Table 137. FATRO Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. FATRO Veterinary Genetic Engineering Vaccines Product
Table 139. FATRO Recent Developments/Updates
Table 140. Ceva Santй Animale Corporation Information
Table 141. Ceva Santй Animale Description and Business Overview
Table 142. Ceva Santй Animale Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Ceva Santй Animale Veterinary Genetic Engineering Vaccines Product
Table 144. Ceva Santй Animale Recent Developments/Updates
Table 145. Pulike Biological Engineering,Inc. Corporation Information
Table 146. Pulike Biological Engineering,Inc. Description and Business Overview
Table 147. Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Pulike Biological Engineering,Inc. Veterinary Genetic Engineering Vaccines Product
Table 149. Pulike Biological Engineering,Inc. Recent Developments/Updates
Table 150. Wuhan Hvsen Biotechnology CO.,LTD Corporation Information
Table 151. Wuhan Hvsen Biotechnology CO.,LTD Description and Business Overview
Table 152. Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Wuhan Hvsen Biotechnology CO.,LTD Veterinary Genetic Engineering Vaccines Product
Table 154. Wuhan Hvsen Biotechnology CO.,LTD Recent Developments/Updates
Table 155. Jinhe Biotechnology Co., Ltd. Corporation Information
Table 156. Jinhe Biotechnology Co., Ltd. Description and Business Overview
Table 157. Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Jinhe Biotechnology Co., Ltd. Veterinary Genetic Engineering Vaccines Product
Table 159. Jinhe Biotechnology Co., Ltd. Recent Developments/Updates
Table 160. Shanghai Shen Lian Biomedical Corporation Corporation Information
Table 161. Shanghai Shen Lian Biomedical Corporation Description and Business Overview
Table 162. Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Shanghai Shen Lian Biomedical Corporation Veterinary Genetic Engineering Vaccines Product
Table 164. Shanghai Shen Lian Biomedical Corporation Recent Developments/Updates
Table 165. Qingdao Vland Biotech INC. Corporation Information
Table 166. Qingdao Vland Biotech INC. Description and Business Overview
Table 167. Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 168. Qingdao Vland Biotech INC. Veterinary Genetic Engineering Vaccines Product
Table 169. Qingdao Vland Biotech INC. Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Veterinary Genetic Engineering Vaccines Distributors List
Table 173. Veterinary Genetic Engineering Vaccines Customers List
Table 174. Veterinary Genetic Engineering Vaccines Market Trends
Table 175. Veterinary Genetic Engineering Vaccines Market Drivers
Table 176. Veterinary Genetic Engineering Vaccines Market Challenges
Table 177. Veterinary Genetic Engineering Vaccines Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Veterinary Genetic Engineering Vaccines
Figure 2. Global Veterinary Genetic Engineering Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Veterinary Genetic Engineering Vaccines Market Share by Type in 2022 & 2029
Figure 4. Genetic Recombinant Vaccine Product Picture
Figure 5. Recombinant Subunit Vaccines Product Picture
Figure 6. Genetic Vaccine Product Picture
Figure 7. Global Veterinary Genetic Engineering Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Veterinary Genetic Engineering Vaccines Market Share by Application in 2022 & 2029
Figure 9. Poultry
Figure 10. Livestock
Figure 11. Other
Figure 12. Global Veterinary Genetic Engineering Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Veterinary Genetic Engineering Vaccines Market Size (2018-2029) & (US$ Million)
Figure 14. Global Veterinary Genetic Engineering Vaccines Sales (2018-2029) & (K Units)
Figure 15. Global Veterinary Genetic Engineering Vaccines Average Price (US$/Unit) & (2018-2029)
Figure 16. Veterinary Genetic Engineering Vaccines Report Years Considered
Figure 17. Veterinary Genetic Engineering Vaccines Sales Share by Manufacturers in 2022
Figure 18. Global Veterinary Genetic Engineering Vaccines Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Veterinary Genetic Engineering Vaccines Players: Market Share by Revenue in 2022
Figure 20. Veterinary Genetic Engineering Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Veterinary Genetic Engineering Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Veterinary Genetic Engineering Vaccines Sales Market Share by Country (2018-2029)
Figure 23. North America Veterinary Genetic Engineering Vaccines Revenue Market Share by Country (2018-2029)
Figure 24. United States Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Veterinary Genetic Engineering Vaccines Sales Market Share by Country (2018-2029)
Figure 27. Europe Veterinary Genetic Engineering Vaccines Revenue Market Share by Country (2018-2029)
Figure 28. Germany Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Veterinary Genetic Engineering Vaccines Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Veterinary Genetic Engineering Vaccines Revenue Market Share by Region (2018-2029)
Figure 35. China Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Veterinary Genetic Engineering Vaccines Sales Market Share by Country (2018-2029)
Figure 43. Latin America Veterinary Genetic Engineering Vaccines Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Colombia Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Veterinary Genetic Engineering Vaccines by Type (2018-2029)
Figure 54. Global Revenue Market Share of Veterinary Genetic Engineering Vaccines by Type (2018-2029)
Figure 55. Global Veterinary Genetic Engineering Vaccines Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Veterinary Genetic Engineering Vaccines by Application (2018-2029)
Figure 57. Global Revenue Market Share of Veterinary Genetic Engineering Vaccines by Application (2018-2029)
Figure 58. Global Veterinary Genetic Engineering Vaccines Price (US$/Unit) by Application (2018-2029)
Figure 59. Veterinary Genetic Engineering Vaccines Value Chain
Figure 60. Veterinary Genetic Engineering Vaccines Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Figure 1. Product Picture of Veterinary Genetic Engineering Vaccines
Figure 2. Global Veterinary Genetic Engineering Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Veterinary Genetic Engineering Vaccines Market Share by Type in 2022 & 2029
Figure 4. Genetic Recombinant Vaccine Product Picture
Figure 5. Recombinant Subunit Vaccines Product Picture
Figure 6. Genetic Vaccine Product Picture
Figure 7. Global Veterinary Genetic Engineering Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Veterinary Genetic Engineering Vaccines Market Share by Application in 2022 & 2029
Figure 9. Poultry
Figure 10. Livestock
Figure 11. Other
Figure 12. Global Veterinary Genetic Engineering Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Veterinary Genetic Engineering Vaccines Market Size (2018-2029) & (US$ Million)
Figure 14. Global Veterinary Genetic Engineering Vaccines Sales (2018-2029) & (K Units)
Figure 15. Global Veterinary Genetic Engineering Vaccines Average Price (US$/Unit) & (2018-2029)
Figure 16. Veterinary Genetic Engineering Vaccines Report Years Considered
Figure 17. Veterinary Genetic Engineering Vaccines Sales Share by Manufacturers in 2022
Figure 18. Global Veterinary Genetic Engineering Vaccines Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Veterinary Genetic Engineering Vaccines Players: Market Share by Revenue in 2022
Figure 20. Veterinary Genetic Engineering Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Veterinary Genetic Engineering Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Veterinary Genetic Engineering Vaccines Sales Market Share by Country (2018-2029)
Figure 23. North America Veterinary Genetic Engineering Vaccines Revenue Market Share by Country (2018-2029)
Figure 24. United States Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Veterinary Genetic Engineering Vaccines Sales Market Share by Country (2018-2029)
Figure 27. Europe Veterinary Genetic Engineering Vaccines Revenue Market Share by Country (2018-2029)
Figure 28. Germany Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Veterinary Genetic Engineering Vaccines Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Veterinary Genetic Engineering Vaccines Revenue Market Share by Region (2018-2029)
Figure 35. China Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Veterinary Genetic Engineering Vaccines Sales Market Share by Country (2018-2029)
Figure 43. Latin America Veterinary Genetic Engineering Vaccines Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Colombia Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Veterinary Genetic Engineering Vaccines Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Veterinary Genetic Engineering Vaccines Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Veterinary Genetic Engineering Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Veterinary Genetic Engineering Vaccines by Type (2018-2029)
Figure 54. Global Revenue Market Share of Veterinary Genetic Engineering Vaccines by Type (2018-2029)
Figure 55. Global Veterinary Genetic Engineering Vaccines Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Veterinary Genetic Engineering Vaccines by Application (2018-2029)
Figure 57. Global Revenue Market Share of Veterinary Genetic Engineering Vaccines by Application (2018-2029)
Figure 58. Global Veterinary Genetic Engineering Vaccines Price (US$/Unit) by Application (2018-2029)
Figure 59. Veterinary Genetic Engineering Vaccines Value Chain
Figure 60. Veterinary Genetic Engineering Vaccines Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
